FIXX Annual Accounts Payable
$3.23 M
+$2.09 M+182.69%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual accounts payable is $3.23 million, with the most recent change of +$2.09 million (+182.69%) on December 1, 2023. During the last 3 years, it has fallen by -$1.49 million (-31.51%).FIXX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly Accounts Payable
$3.23 M
-$4.57 M-58.55%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly accounts payable is $3.23 million, with the most recent change of -$4.57 million (-58.55%) on December 1, 2023. Over the past year, it has dropped by -$4.57 million (-58.55%).FIXX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +182.7% | -58.5% |
| 3 y3 years | -31.5% | -58.5% |
| 5 y5 years | -79.4% | -58.5% |
FIXX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -79.4% | -79.4% |
Homology Medicines Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $3.23 M(+182.7%) | $3.23 M(-58.6%) |
| Sept 2023 | - | $7.80 M(+130.0%) |
| June 2023 | - | $3.39 M(-6.7%) |
| Mar 2023 | - | $3.63 M(+217.7%) |
| Dec 2022 | $1.14 M(-51.6%) | $1.14 M(-76.3%) |
| Sept 2022 | - | $4.83 M(+28.5%) |
| June 2022 | - | $3.76 M(-61.9%) |
| Mar 2022 | - | $9.88 M(+317.8%) |
| Dec 2021 | $2.37 M(-49.9%) | $2.37 M(-32.8%) |
| Sept 2021 | - | $3.52 M(-38.2%) |
| June 2021 | - | $5.70 M(+16.8%) |
| Mar 2021 | - | $4.88 M(+3.3%) |
| Dec 2020 | $4.72 M | $4.72 M(+42.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $3.32 M(-53.3%) |
| June 2020 | - | $7.10 M(-4.0%) |
| Mar 2020 | - | $7.40 M(+183.7%) |
| Dec 2019 | $2.61 M(-83.4%) | $2.61 M(-70.4%) |
| Sept 2019 | - | $8.80 M(+5.6%) |
| June 2019 | - | $8.33 M(-29.3%) |
| Mar 2019 | - | $11.79 M(-25.0%) |
| Dec 2018 | $15.73 M(+519.9%) | $15.73 M(+41.5%) |
| Sept 2018 | - | $11.12 M(+121.6%) |
| June 2018 | - | $5.02 M(+32.9%) |
| Mar 2018 | - | $3.78 M(+48.8%) |
| Dec 2017 | $2.54 M(+184.0%) | $2.54 M |
| Dec 2016 | $893.70 K | - |
FAQ
- What is Homology Medicines annual accounts payable?
- What is the all time high annual accounts payable for Homology Medicines?
- What is Homology Medicines annual accounts payable year-on-year change?
- What is Homology Medicines quarterly accounts payable?
- What is the all time high quarterly accounts payable for Homology Medicines?
- What is Homology Medicines quarterly accounts payable year-on-year change?
What is Homology Medicines annual accounts payable?
The current annual accounts payable of FIXX is $3.23 M
What is the all time high annual accounts payable for Homology Medicines?
Homology Medicines all-time high annual accounts payable is $15.73 M
What is Homology Medicines annual accounts payable year-on-year change?
Over the past year, FIXX annual accounts payable has changed by +$2.09 M (+182.69%)
What is Homology Medicines quarterly accounts payable?
The current quarterly accounts payable of FIXX is $3.23 M
What is the all time high quarterly accounts payable for Homology Medicines?
Homology Medicines all-time high quarterly accounts payable is $15.73 M
What is Homology Medicines quarterly accounts payable year-on-year change?
Over the past year, FIXX quarterly accounts payable has changed by -$4.57 M (-58.55%)